Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
Share
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
Army Launches Joint Innovation Outpost to Accelerate Battlefield Capabilities
At Fort Bragg, the XVIII Airborne Corps’ Joint Innovation Outpost connects soldiers, engineers and industry to accelerate battlefield capability development.
23m listen -
Federal Courts Use GIS to Improve Security, Visitor Experience
The Administrative Office of the Courts is using geospatial intelligence systems data to integrate security systems, enhance safety and improve the visitor experience.
13m listen -
AI Decision Support System Aims to Improve Battlefield Triage
APPRAISE helps combat medics identify hemorrhage risk earlier and make faster triage and evacuation decisions.
7m watch -
VA Deputy Secretary on Resuming EHR Rollout
VA resumed rollout of its EHRM program this weekend after a three-year pause, and Paul Lawrence discusses early feedback and lessons learned.
15m watch
